白血病占儿童肿瘤首位!科学家联合使用免疫细(2)
随着科学家们的不懈努力,儿童白血病已不再是人们眼中无法治愈的绝症,但复发难治型急性淋巴细胞白血病的治疗仍是一块难啃的硬骨头,是儿童白血病诊疗中的难点、痛点。近期发表于《临床肿瘤学杂志》的这项研究给我们展现了科学家们的最新成果,相信未来,随着临床试验的广泛开展,将会有更多的患者受益于这项研究。
参考文献:
[1]平凌燕.CAR-T细胞治疗复发难治儿童及青少年CD19~+急性淋巴细胞白血病管理指南解读[J].肿瘤综合治疗电子杂志,2018,4(04):21-26.
SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med. 2013 Apr 18;368(16):1509-1518. doi: 10.1056/NEJMoa. Epub 2013 Mar 25. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998. PMID: ; PMCID: PMC.
SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, Lacey SF, Mahnke YD, Melenhorst JJ, Rheingold SR, Shen A, Teachey DT, Levine BL, June CH, Porter DL, Grupp SA. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014 Oct 16;371(16):1507-17. doi: 10.1056/NEJMoa. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998. PMID: ; PMCID: PMC.
NN, Lee DW, Yates B, Yuan CM, Shalabi H, Martin S, Wolters PL, Steinberg SM, Baker EH, Delbrook CP, Stetler-Stevenson M, Fry TJ, Stroncek DF, Mackall CL. Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL. J Clin Oncol. 2021 Mar 25:JCO. doi: 10.1200/ Epub ahead of print. PMID: .
文章来源:《肿瘤》 网址: http://www.zlzzs.cn/zonghexinwen/2021/0512/1313.html